Age, specialty, and practice setting predict gastroesophageal reflux disease prescribing behavior

Journal of Clinical Gastroenterology

Volumn 39, Issue 6, 2005, Pages 489-494

  Lacy, Brian E ^a,c   Crowell, Michael D ^b   Riesett, Randal P ^a   Mitchell, Amy ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Acid suppression; Gastroesophageal reflux disease; Histamine type 2 receptor antagonists; Practice patterns; Proton pump inhibitors

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; ENDOSCOPY; GASTROENTEROLOGY; GASTROESOPHAGEAL REFLUX; GENERAL PRACTITIONER; HEALTH MAINTENANCE ORGANIZATION; HUMAN; MEDICAL SPECIALIST; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE;

ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; FEMALE; GASTROESOPHAGEAL REFLUX; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MARYLAND; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG; PROFESSIONAL PRACTICE LOCATION; PROTON PUMPS; QUESTIONNAIRES; SPECIALTIES, MEDICAL; UNITED STATES;

EID: 20844458111     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000165647.24748.04     Document Type: Article

References (20)

1. Gallup Organization. A Gallup Survey on Heartburn Across America. Princeton, NJ: Gallup Organization, 1988.
2. Locke GR, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology. 1997;112:1448-1456.
3. Isenberg JI, Donowitz M. The Burden of Gastrointestinal Diseases: American Gastroenterology Association Report. American Gastroenterology Association, 2001.
4. Dimenas E. Methodological aspects of evaluation of quality of life in upper gastrointestinal disease. Scand J Gastroenterol. 1993;28: 18-21.
5. Revicki DA, Wood M, Maton PN, et al. The impact of gastroesophageal reflux disease on health-related quality of life. Am J Med. 1998;104:252-258.
6. Monnier P, Ollyo JB, Fontolliet C, et al. Epidemiology and natural history of reflux esophagitis. Semin Lap Surg. 1995;2:2-9.
7. Lagergren J, Bergstrom R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825-831.
8. Castell DO, Brunton SA, Earnest DL, et al. GERD: management algorithms for the primary care physician and the specialist. Prac Gastroenterol. 1999;2:20-44.
9. DeVault K, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol. 1999; 1434-1442.
10. Hetzel DJ, Dent J, Reed WD, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology. 1988;95: 903-912.
11. McDougall NI, Johnston BT, Kee F, et al. Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life. Gut. 1996;38:481-486.
12. Tanouye E. Battle brews in the heartburn business as two old drugs go over the counter. Wall Street Journal. 1995.
13. Fennerty MB, Castell D, Fendrick AM, et al. The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment. Arch Intern Med. 1996;156:477-484.
14. Kahrilas PJ. Gastroesophageal reflux disease. JAMA. 1996;276:983-988.
15. Zagari M, Villa FK, Freston JW. Proton pump inhibitors versus H2-receptor antagonists for the treatment of erosive gastroesophageal reflux disease: a cost-comparative study. Pharmacoeconomics. 1995;1:247-255.
16. Harris RA, Kuppermann M, Richter JE. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis. Am J Gastroenterol. 1997;92:2179-2187.
17. Gerson LB, Robbins AS, Garber A, et al. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease. Am J Gastroenterol. 2000;95:395-407.
18. Koehler RE, Weyman PJ, Oakley HF. Single- and double-contrast techniques in esophagitis. AJR Am J Roentgenol. 1980;135:15-19.
19. Graziani L, De Nigris E, Pesaresi A. Reflux esophagitis: radiologic-endoscopic correlation in 39 symptomatic cases. Gastrointest Radiol. 1983;8:1-6.
20. Inadomi JM, McIntyre L, Bernard L, et al. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs. Am J Gastroenterol. 2003;98:1940-1944.